{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T21:33:32Z","timestamp":1781904812520,"version":"3.54.5"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Osteoporosis treatment guidelines recommend assessment for potential causes of secondary osteoporosis, however, there are limited data evaluating the yield of laboratory tests recommended for routine screening. The purpose of this study was to quantify the frequency of abnormal laboratory results indicative of secondary osteoporosis in patients referred to a Metabolic Bone Clinic with a diagnosis of low bone density or fracture. A retrospective chart review was conducted on 890 consecutive patients at a tertiary academic medical center from October 2018 to December 2021. Upon referral, patients were asked to complete a standardized set of laboratory tests, including comprehensive metabolic panel, 25OHD, PTH, thyroid testing, complete blood count, phosphorus, tissue transglutaminase antibodies, and 24-h urine calcium with creatinine. Among 890 patients, 67% of subjects had at least one laboratory abnormality. The most common abnormalities were of 25OHD and PTH with 22.4% and 19.1% of each test respectively showing abnormal results. Over 99% of serologic testing was completed; however, urine calcium testing was completed in only 34% of subjects. Among individuals who completed 24-h urine calcium testing (n\u2009=\u2009304), 26.5% had hypocalciuria (&amp;lt;100\u00a0mg\/24\u00a0h), and 25.2% had hypercalciuria (&amp;gt;250\u00a0mg\/24\u00a0h). Subjects with a Z-score &amp;lt;\u22122.0 were more likely to have abnormal laboratory results. This study demonstrates that laboratory abnormalities indicating secondary osteoporosis are very common among patients with low bone density and fracture. Systematic laboratory testing with a circumspect number of tests is appropriate in all patients with skeletal fragility.<\/jats:p>","DOI":"10.1093\/jbmrpl\/ziaf089","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T21:08:22Z","timestamp":1747516102000},"source":"Crossref","is-referenced-by-count":1,"title":["High prevalence of laboratory abnormalities indicative of secondary osteoporosis detected by systematic testing"],"prefix":"10.1093","volume":"9","author":[{"given":"Nandi","family":"Shah","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Endocrinology and Diabetes, University of California , San Diego, CA 92093 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley","family":"Galitzer","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Gerontology, and Metabolism, Stanford University School of Medicine , Palo Alto, CA 94305 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swaytha","family":"Yalamanchi","sequence":"additional","affiliation":[{"name":"Palo Alto Medical Foundation , Palo Alto, CA 94301 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4571-1386","authenticated-orcid":false,"given":"Deborah E","family":"Sellmeyer","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Gerontology, and Metabolism, Stanford University School of Medicine , Palo Alto, CA 94305 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,17]]},"reference":[{"issue":"11","key":"2025062622305531100_ref1","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1002\/jbmr.2269","article-title":"The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine","volume":"29","author":"Wright","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"9","key":"2025062622305531100_ref2","doi-asserted-by":"publisher","first-page":"e10192","DOI":"10.1002\/jbm4.10192","article-title":"Healthcare policy changes in osteoporosis can improve outcomes and reduce costs in the United States","volume":"3","author":"Lewiecki","year":"2019","journal-title":"JBMR Plus"},{"issue":"6","key":"2025062622305531100_ref3","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"285","author":"NIH Consensus Development Panel on Osteoporosis Prevention, D. and Therapy","year":"2001","journal-title":"JAMA"},{"key":"2025062622305531100_ref4","doi-asserted-by":"publisher","first-page":"2021;8:780087","DOI":"10.3389\/fmed.2021.780087","article-title":"Hypercalciuria in postmenopausal women with reduced bone mineral density is associated with different mineral metabolic profiles: effects of treatment with thiazides and anti-resorptives","author":"Nicoli","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"2025062622305531100_ref5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s00774-021-01279-2","article-title":"Skeletal effects of combined bisphosphonates treatment and parathyroidectomy in osteoporotic patients with primary hyperparathyroidism","volume":"40","author":"Choe","year":"2022","journal-title":"J Bone Miner Metab"},{"issue":"3","key":"2025062622305531100_ref6","first-page":"729","article-title":"Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism","volume":"80","author":"Silverberg","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025062622305531100_ref7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.7326\/0003-4819-120-1-199401010-00002","article-title":"Thyrotoxic bone disease in women: a potentially reversible disorder","volume":"120","author":"Diamond","year":"1994","journal-title":"Ann Intern Med"},{"issue":"1","key":"2025062622305531100_ref8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s00198-004-1641-2","article-title":"Calcium absorption and bone mineral density in celiacs after long term treatment with gluten-free diet and adequate calcium intake","volume":"16","author":"Pazianas","year":"2005","journal-title":"Osteoporos Int"},{"issue":"11","key":"2025062622305531100_ref9","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1155\/2012\/823648","article-title":"Evaluation and management of skeletal health in celiac disease: position statement","volume":"26","author":"Fouda","year":"2012","journal-title":"Can J Gastroenterol"},{"issue":"10","key":"2025062622305531100_ref10","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.1210\/jc.2002-020275","article-title":"Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women","volume":"87","author":"Tannenbaum","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025062622305531100_ref11","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1007\/s00198-010-1421-0","article-title":"Osteoporosis in men: the value of laboratory testing","volume":"22","author":"Ryan","year":"2011","journal-title":"Osteoporos Int"},{"issue":"2","key":"2025062622305531100_ref12","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1210\/endrev\/bnab028","article-title":"Secondary osteoporosis","volume":"43","author":"Ebeling","year":"2022","journal-title":"Endocr Rev"},{"issue":"6","key":"2025062622305531100_ref13","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1210\/jc.2011-3045","article-title":"Osteoporosis in men: an Endocrine Society Clinical Practice Guideline","volume":"97","author":"Watts","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025062622305531100_ref14","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1210\/jc.2019-00221","article-title":"Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society* Clinical Practice Guideline","volume":"104","author":"Eastell","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"2025062622305531100_ref15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/GL-2020-0524SUPPL","article-title":"American Association of Clinical Endocrinologists\/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis-2020 update","volume":"26","author":"Camacho","year":"2020","journal-title":"Endocr Pract"},{"issue":"10","key":"2025062622305531100_ref16","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","article-title":"The clinician's guide to prevention and treatment of osteoporosis","volume":"33","author":"LeBoff","year":"2022","journal-title":"Osteoporos Int"},{"issue":"2","key":"2025062622305531100_ref17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1177\/2151458513501176","article-title":"The value of laboratory tests in diagnosing secondary osteoporosis at a fracture and osteoporosis outpatient clinic","volume":"4","author":"de Klerk","year":"2013","journal-title":"Geriatr Orthop Surg Rehabil"},{"issue":"1","key":"2025062622305531100_ref18","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00198-015-3356-y","article-title":"Clinical utility of routine laboratory testing to identify possible secondary causes in older men with osteoporosis: the osteoporotic fractures in men (MrOS) study","volume":"27","author":"Fink","year":"2016","journal-title":"Osteoporos Int"},{"issue":"2","key":"2025062622305531100_ref19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ando.2022.01.002","article-title":"A retrospective study on the etiological exploration of osteoporosis in aging men in a French geriatric setting","volume":"83","author":"Litke","year":"2022","journal-title":"Ann Endocrinol"},{"issue":"1","key":"2025062622305531100_ref20","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s11657-023-01321-y","article-title":"A diagnostic predictive model for secondary osteoporosis in patients with fragility fracture: a retrospective cohort study in a tertiary care hospital","volume":"18","author":"Phudphong","year":"2023","journal-title":"Arch Osteoporos"},{"issue":"8","key":"2025062622305531100_ref21","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1210\/clinem\/dgaa306","article-title":"Osteoporosis in premenopausal women: a clinical narrative review by the ECTS and the IOF","volume":"105","author":"Pepe","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025062622305531100_ref22","doi-asserted-by":"publisher","first-page":"537","DOI":"10.4183\/aeb.2021.537","article-title":"Surprisingly few women with severe osteoporosis by bone densitometry undergo workup for secondary causes - a retrospective evaluation","volume":"17","author":"Nguyen","year":"2021","journal-title":"Acta Endocrinol"},{"key":"2025062622305531100_ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-015-0226-3","article-title":"Yield and cost-effectiveness of laboratory testing to identify metabolic contributors to falls and fractures in older persons","volume":"10","author":"Johnson","journal-title":"Arch Osteoporos"},{"issue":"5","key":"2025062622305531100_ref24","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1210\/jc.2010-2135","article-title":"Contributors to secondary osteoporosis and metabolic bone diseases in patients presenting with a clinical fracture","volume":"96","author":"Bours","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025062622305531100_ref25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1530\/EJE-13-0102","article-title":"Prevalence of subclinical contributors to low bone mineral density and\/or fragility fracture","volume":"169","author":"Eller-Vainicher","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2025062622305531100_ref26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1089\/jwh.2008.0887","article-title":"Clinical characteristics and medication use among premenopausal women with osteoporosis and low BMD: the experience of an osteoporosis referral center","volume":"18","author":"Cohen","year":"2009","journal-title":"J Womens Health (Larchmt)"},{"issue":"1","key":"2025062622305531100_ref27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11657-017-0324-5","article-title":"UK clinical guideline for the prevention and treatment of osteoporosis","volume":"12","author":"Compston","year":"2017","journal-title":"Arch Osteoporos"},{"issue":"1","key":"2025062622305531100_ref28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"30","author":"Kanis","year":"2019","journal-title":"Osteoporos Int"},{"issue":"5","key":"2025062622305531100_ref29","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/8756-3282(94)90280-1","article-title":"Epidemiology and clinical features of osteoporosis in young individuals","volume":"15","author":"Khosla","year":"1994","journal-title":"Bone"},{"issue":"1","key":"2025062622305531100_ref30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1053\/sarh.2002.33725","article-title":"Clinical characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish women","volume":"32","author":"Peris","year":"2002","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"2025062622305531100_ref31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1056\/NEJMoa2202106","article-title":"Supplemental vitamin D and incident fractures in midlife and older adults","volume":"387","author":"LeBoff","year":"2022","journal-title":"N Engl J Med"},{"issue":"7","key":"2025062622305531100_ref32","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J Clin Endocrinol Metab"}],"container-title":["JBMR Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmrplus\/advance-article-pdf\/doi\/10.1093\/jbmrpl\/ziaf089\/63217145\/ziaf089.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/9\/7\/ziaf089\/63217145\/ziaf089.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/9\/7\/ziaf089\/63217145\/ziaf089.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T02:31:03Z","timestamp":1750991463000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article\/doi\/10.1093\/jbmrpl\/ziaf089\/8134274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,17]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,6,5]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmrpl\/ziaf089","relation":{},"ISSN":["2473-4039"],"issn-type":[{"value":"2473-4039","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,5,17]]},"article-number":"ziaf089"}}